Yan, Xiaowei

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine

COVID-19 Clinical Research StudiesSystemic Lupus Erythematosus Research

Cited by 2,179

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., Wang, J., Qin, Y., Zhang, X., Yan, X., et al. (2020) · Clinical Immunology

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 1,266

Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction

Liu, X., Wang, Y., Lu, H., Li, J., Yan, X., Xiao, M., Hao, J., Alekseev, A., Khong, H., Chen, T., et al. (2019) · Nature

T-cell and B-cell ImmunologyNuclear Receptors and Signaling

Cited by 533